{"id":15882,"date":"2012-11-27T01:30:00","date_gmt":"2012-11-27T00:30:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/morire-di-profitto\/"},"modified":"2012-11-27T01:30:00","modified_gmt":"2012-11-27T00:30:00","slug":"morire-di-profitto","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/morire-di-profitto\/","title":{"rendered":"To die of profit"},"content":{"rendered":"<p class=\"MsoNormal\" style=\"text-align: left; line-height: normal; margin: 0cm 0cm 10pt; background: white; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-outline-level: 3\"><b><span style=\"font-family: &quot;PT Sans&quot;; color: black; font-size: 13.5pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: IT\"><font face=\"Calibri\">26\/11\/2012 \u2013 This is how pharmaceutical companies prefer money to health <\/p>\n<p><\/font><\/span><\/b><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; margin: 0cm 0cm 10pt\"><span style=\"font-family: &quot;PT Sans&quot;; color: black\"><font size=\"3\" face=\"Calibri\">What if it were the pharmaceutical companies that prevented the search for new treatments and hindered doctors and scientists in their work of prevention and experimentation of systems for early diagnosis? The <\/font><a title=\"Washington Post: As drug industry&#039;s influence over research grows, so does the potential for bias\" target=\"_blank\" href=\"http:\/\/www.washingtonpost.com\/business\/economy\/as-drug-industrys-influence-over-research-grows-so-does-the-potential-for-bias\/2012\/11\/24\/bb64d596-1264-11e2-be82-c3411b7680a9_story.html\" rel=\"noopener\"><font color=\"#0000ff\" size=\"3\" face=\"Calibri\">Washington Post<\/font><\/a><font size=\"3\"><font face=\"Calibri\"> published a long investigation on Sunday which reveals, at least in part, the background of a famous drug for the treatment of diabetes, produced by the British giant <strong><span style=\"font-family: &quot;PT Sans&quot;; mso-bidi-font-family: 'Times New Roman'; mso-bidi-theme-font: minor-bidi\">GlaxoSmithKline<\/span><\/strong>, and withdrawn a few years later.<span class=\"MsoHyperlink\"><span style=\"color: black\"><u> <\/p>\n<p><\/u><\/span><\/span><\/font><\/font><\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; margin: 0cm 0cm 10pt\"><font size=\"3\"><font face=\"Calibri\"><strong><span style=\"font-family: &quot;PT Sans&quot;; color: black; mso-bidi-font-family: 'Times New Roman'; mso-bidi-theme-font: minor-bidi\">THE BEST DRUG \u2013<\/span><\/strong><span style=\"font-family: &quot;PT Sans&quot;; color: black\"> It all began in 2006 when, after a long experimentation, the vice president <strong><span style=\"font-family: &quot;PT Sans&quot;; mso-bidi-font-family: 'Times New Roman'; mso-bidi-theme-font: minor-bidi\">Lawson Macartney<\/span><\/strong> announces that, out of three drugs tested, <strong><span style=\"font-family: &quot;PT Sans&quot;; mso-bidi-font-family: 'Times New Roman'; mso-bidi-theme-font: minor-bidi\">Avadia<\/span><\/strong> was the best in the treatment of diabetes. It is a pity that, reading the report carefully, one discovers that the experimentation was financed by GlaxoSmithKline and that the aforementioned final report was drawn up by eleven people, all financed by the company, just like the seven academics who received substantial contributions for the their consultancy work. Furthermore, but this will only be discovered later, Avadia increases the risk of heart disease in patients treated with this drug which, within four years, has practically disappeared from the market.<\/p>\n<p><\/span><\/font><\/font><\/p>\n<p style=\"text-align: left; background: white\"><font size=\"3\"><font face=\"Times New Roman\"><strong><span style=\"font-family: &quot;PT Sans&quot;; color: black\">DANGEROUS SIDE EFFECTS \u2013<\/span><\/strong><span style=\"font-family: &quot;PT Sans&quot;; color: black\"> Pharmaceutical companies, continues the Washington Post, are investing billions of dollars in testing new treatments. But their purpose is not just public health. Because those investments are part of a relentless pursuit of profits that have, in recent decades, interfered with medicine, often with lethal consequences. Avandia isn&#039;t the only case: controversies around drugs like the <strong><span style=\n\"<\/p\">","protected":false},"excerpt":{"rendered":"<p>26\/11\/2012 &#8211; Cos&igrave; le aziende farmaceutiche preferiscono i soldi alla salute E se fossero proprio la case farmaceutiche a impedire la ricerca di nuova cure e a intralciare medici e scienziati nel loro lavoro di prevenzione e di sperimentazione di sistemi per la diagnosi precoce? Il Washington Post ha pubblicato domenica una lunga inchiesta che &hellip;<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-15882","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/15882","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=15882"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/15882\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=15882"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=15882"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=15882"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}